Health care issues dominate the policy agenda in Washington, D.C. Stakeholders in health care—from those at the forefront of delivering care to those bringing forward innovations for patients and consumers—face a dynamic environment defined by rapidly changing health care regulations, fast-moving technological advancements and an evolving policy landscape. 

Health care stakeholders must remain sharply attuned to and engaged in how the myriad, ongoing policy & legislative developments may impact the way they do business.

Our health policy & legislation team is nationally recognized for experience in legislative and public policy matters affecting a wide range of health care and related entities. We advise on the full array of policy issues and legislation related to health care & life sciences. We also have an active federal funding practice that has succeeded in securing funding for our clients around numerous initiatives.

Many of our practitioners have served in high-ranking positions in administrative agencies and on congressional committees. We bring this experience in advising on matters before the:

  • House Ways and Means, Energy and Commerce, and Education and Labor committees
  • Senate Finance and Health, Education, Labor and Pensions (HELP) committees
  • House and Senate Appropriations committees
  • U.S. Department of Health and Human Services (HHS), including the Centers for Medicare and Medicaid Services (CMS) and the Food and Drug Administration (FDA)
  • U.S. Department of Labor (DOL)
  • U.S. Department of the Treasury
  • Medicare Payment Advisory Commission (MedPAC)
  • Medicaid and CHIP Payment and Access Commission (MACPAC).

We assist players across the health care & life sciences sector, including drug and biologics companies, medical device and technology manufacturers, hospitals and health care systems, physician groups and specialty associations, and patient advocacy groups. On their behalf, our team develops advocacy strategies and effective alliances to advance their interests before Congress and federal agencies, key advisory bodies and other policy influencers.

We also are skilled at identifying and building markets for clients through legislative and regulatory advocacy to influence policy developments.

Health Policy & Legislation Insights

      Blog | Eye on FDA

      December 2, 2024

      Read More

          Blog | Eye on FDA

          December 2, 2024

          Read More

          Health Policy & Legislation Lawyers and Advisors

          Health Policy & Legislation Awards and Accolades

            Awards and Accolades

              Awards and Accolades

                Awards and Accolades

                  Awards and Accolades

                    Awards and Accolades

                      Awards and Accolades

                      We Also Recommend

                      Loading...
                      Loading...
                      Loading...
                      Loading...